Mendlein John insider trades
Mendlein John has filed 11 Form 4s with the SEC that we hold, for Fate Therapeutics INC (FATE) (Director) and OMGA (Director). Across all of them we count 2 purchases worth $698.1K and 3 sales worth $1.1M reported on Form 4. None of these purchases or sales is dated in the last 12 months. The largest single trade was a sale of 19,493 shares of Fate Therapeutics INC worth $677.0K, dated 2022-03-10. The first filing on our record is dated 2022-03-11 and the latest 2025-05-30.
Fate Therapeutics INC (FATE)
| Trade date | Code | Shares | Value as filed | Filed |
|---|---|---|---|---|
| 2022-03-10 | S, sale reported on Form 4 | 12,069 | $428.2K | 2022-03-11 |
| 2022-03-10 | S, sale reported on Form 4 | 19,493 | $677.0K | 2022-03-11 |
| 2022-06-03 | S, sale reported on Form 4 | 1,364 | $31.1K | 2022-06-06 |
| 2023-01-11 | P, purchase reported on Form 4 | 88,048 | $499.2K | 2023-01-13 |
| 2023-01-13 | P, purchase reported on Form 4 | 36,631 | $198.9K | 2023-01-13 |
OMGA
No purchase or sale of common stock reported here; these filings cover grants, option exercises or other codes.
Counted from the Form 4 filings this reporting owner (SEC CIK 1238362) filed on EDGAR. Values are the transaction values as filed. See every filing on EDGAR, or browse insider buying and today's insider purchases.
Source: U.S. Securities and Exchange Commission (EDGAR) and other official
government data · Updated 2026-10-12 ·
For informational purposes only, not investment advice.
Privacy · Terms